Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Traws Pharma, Inc. (NASDAQ:TRAW) with a Buy rating and announced a price target of $8. Traws Pharma shares closed at $2.16 on Tuesday. See how other analysts view this stock.
- Canaccord Genuity analyst John Newman initiated coverage on Compass Therapeutics, Inc. (NASDAQ:CMPX) with a Buy rating and announced a price target of $10. Compass Therapeutics shares closed at $5.22 on Tuesday. See how other analysts view this stock.
- CICC analyst Shanshan Shen initiated coverage on Linde plc (NASDAQ:LIN) with an Outperform rating and announced a price target of $510. Linde shares closed at $408.79 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Pelthos Therapeutics Inc. (AMEX:PTHS) with a Buy rating and announced a price target of $60. Pelthos Therapeutics shares closed at $25.14 on Tuesday. See how other analysts view this stock.
- LifeSci Capital initiated coverage on Oculis Holding AG (NASDAQ:OCS) with an Outperform rating and announced a price target of $55. Oculis Holding shares closed at $18.79 on Tuesday. See how other analysts view this stock.
Considering buying LIN stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock